Latest Cash Management News

ImpediMed Limited reported a record quarter for its SOZO device sales with $6.3 million in contracts, supported by expanded US reimbursement coverage and new funding. Despite stable revenue, the company’s cost-cutting and strategic moves position it well for growth in FY26.

James Bay Minerals reports robust drill results with high-grade gold intercepts and a 184% landholding increase at its Independence Gold Project in Nevada, while advancing a Scoping Study for near-surface oxide gold development.

4DS Memory Limited reports mixed progress in its June 2025 quarter, with ongoing root cause analysis into unexpected wafer test results and a stable cash position of $10.2 million.

Caravel Minerals has secured a $15 million non-dilutive loan facility to fund the Definitive Feasibility Study for its Caravel Copper Project, alongside finalising a simplified process flowsheet and initiating key engineering tenders.

Locality Planning Energy Holdings has appointed Craig Chambers as Chairman and reported a cashflow positive year, reaffirming a net profit guidance of $3.0 to $3.5 million for FY25.

Orbital Corporation reports a $0.5 million operating cash outflow for Q2 2025, while progressing development of a larger UAV engine now entering customer flight trials.

Volt Resources reports robust progress on its Alabama Graphite Refinery scoping study, strategic partnerships in Tanzania, and resilient production in Ukraine, positioning itself strongly amid evolving graphite market dynamics.

Gladiator Resources reported promising uranium and rare metal findings at its Tanzanian projects while initiating legal action over alleged defamation, all against a backdrop of cautious cash management.

Uscom Limited reported a significant revenue decline in Q4 2025 amid global market instability but is focusing on cost management and strategic partnerships to position for recovery.

Ragusa Minerals has completed a $427,200 capital raise as it reviews new project opportunities to complement its Burracoppin rare earth and kaolin assets. The company also ended key agreements and maintains a lean cash position heading into the next phase.

ENRG Elements Limited has appointed new management and implemented significant cost reductions while renewing key uranium exploration permits in Niger. The company is also exiting lithium projects in Canada to focus on core assets and new opportunities.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.